Kyowa Kirin, Pola Orbis HD, etc. (additional) Rating.
Target Price Change Code Stock Name Securities Company Previous Changed After-------------------------------------------<5406> Kobe Steel Morgan Stanley 1700 yen 1900 yen <5411> JFE Morgan Stanley 1900 yen 2150 yen <7956> Pigeon Daiwa 1520 yen 1890 yen <8750> Dai-ichi Life HD Morgan Stanley 5310 yen 5450 yen <8795> T&D HD Morgan Stanley 3290 yen 3360 yen <9201> JAL GS29
Eisai, Taiyo Yuden, ETC [List of stock materials from the newspaper]
*V Technology <7717> enters laser dicing, aiming for practical use next year (Nikkan Kogyo, front page) -○ *Kanadevia <7004> implements measures to prevent recurrence of marine engine fuel economy fraud (Nikkan Kogyo, page 3) -○ *Eisai <4523> plans to reduce 30 billion yen by FY2026, optimizing the organization (Nikkan Kogyo, page 3) -○ *Petroleum Resource Development <1662> sells its UK subsidiary for 33.6 billion yen in oil field development (Nikkan Kogyo, page 4) -○ *ENEOSHD <5020> ENEOS produces lubricants and more at the Yokohama plant.
A steady and resilient U.S. Stocks market is providing support.
[Global Strategy for Emerging Markets] Today's emerging markets are expected to have a steady performance. Yesterday, on the 25th, the Dow Inc in the US stock market rose by 4.18 dollars (+0.01%) to 42,587.50 dollars, marking a slight increase for three consecutive days. The buying was supported by President Trump's suggestion of a flexible stance regarding 'reciprocal tariffs'. On the other hand, due to the deterioration in the consumer confidence Index ETF, concerns over economic slowdown caused the market to temporarily decline, but a drop in long-term interest rates supported the market, allowing it to recover into positive territory. Today's emerging markets are favored for buying.
List of conversion stocks [List of parabolic signal conversion stocks]
○ List of stocks for Buy conversion in the market Code Stock Name Closing Price SAR Main Board <2384> SBS Holdings 2942 2787 <262A> Intermezzotic 17701651 <3099> Mitsukoshi Isetan 22882149 <3151> Vital KSK 12391151 <3199> Watahann HD 17341629 <3371> Soft Creative 20631996 <3393> Startia
Station Investigation, Value C and others [Emerging Markets Press Release]
<3646> Station exploration performance estimate revision, this period's operating profit forecast is 0.103 billion yen, revised from 0.101 billion yen. <4582> Symbio Pharmaceuticals issued the 7th unsecured Convertible Bonds with subscription rights (number of potential Stocks is 3.8 million, and the funds raised are approximately 0.6 billion yen). <4586> Medrek de Western Therapeutics is co-developing the MRX-5LBT approval application in the USA. <9211> F-Code's acquisition of treasury shares has ended. <9238> Value C Digital Plus <3691>
Sasmid's business expansion following the insomnia treatment app is proceeding smoothly.
Sasmid <4263> has set the Task Center to "continue to provide sustainable Veterinary Services to society through the utilization of ICT," and is a venture company in the research and development stage that develops digital therapeutics (Digital Therapeutics, hereinafter referred to as DTx), which is gaining attention as the third treatment method following Pharmaceuticals and Medical Devices. The company is engaged in the DTx product business that develops therapeutic applications and the DTx platform business that supports clinical trial efficiency for pharmaceutical companies.